retatrutide and mounjaro (“reta”) is an experimental weight-loss drug currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic Mounjaro—but more powerful. The reason comes down to how it works Mounjaro rivals Wegovy and Retatrutide

Similar results were observed with another once-weekly GLP-1RA (exenatide), in which subgroup analyses showed a consistent reduction in MACE across a range of baseline characteristics, including gender, age, and previous CV events [29]

Certain medications, like antidepressants or antipsychotics, can interact with GLP-1 medication, affecting its efficacy in helping individuals lose weight

PCA of the RNA-seq data revealed substantial differences in intestinal gene expression between WT and sterile mutant strains

Effect of Oral Semaglutide on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol in Healthy Postmenopausal Women and Furosemide and Rosuvastatin in Healthy Subjects

Can You Tan Without Sun Exposure